Arch Esp Urol 2017 Apr;70(3):361-366
Servicio de Urología. Complejo Asistencial de Avila. España.
J Urol 2013 Apr 27;189(4):1214-21. Epub 2012 Sep 27.
Department of Urology, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York.
Purpose: Urothelial carcinoma of the bladder is the 4th most common malignancy in men and the 8th most common cause of male cancer death in the United States. Conversely, upper tract urothelial carcinoma accounts for only 5% to 10% of all urothelial carcinoma. Due to the relative preponderance of urothelial carcinoma of the bladder, much of the clinical decision making regarding upper tract urothelial carcinoma is extrapolated from evidence that is based on urothelial carcinoma of the bladder cohorts. Read More
World J Surg Oncol 2016 Oct 20;14(1):270. Epub 2016 Oct 20.
Department of Urology, Center for Prostate Cancer, Research Institute and Hospital of National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 410-769, South Korea.
Background: Sarcomatoid urothelial carcinoma (SUC) is a rare malignant neoplasm of the urinary bladder comprising 0.2-0.6 % of all histological bladder tumor subtypes. Read More
Eur Urol 2015 Nov 16;68(5):868-79. Epub 2015 Jul 16.
Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna General Hospital, Vienna, Austria; Department of Urology, Weill Medical College of Cornell University, New York, NY, USA; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Context: The European Association of Urology (EAU) guidelines panel on upper urinary tract urothelial cell carcinoma (UTUC) has prepared updated guidelines to aid clinicians in the current evidence-based management of UTUC and to incorporate recommendations into clinical practice.
Objective: To provide a brief overview of the EAU guidelines on UTUC as an aid to clinicians.
Evidence Acquisition: The recommendations provided in the current guidelines are based on a thorough review of available UTUC guidelines and articles identified following a systematic search of Medline. Read More
Hinyokika Kiyo 1993 Oct;39(10):927-30
Department of Urology, Hyogo Medical Center for Adults.
A 49-year-old male with left renal cell carcinoma and urothelial cancer (bladder and residual left ureter), which asynchronously occurred, was reported. He had received radical nephrectomy due to renal cell carcinoma 12 years earlier. He was followed up by his local physician for 7 years postoperatively, during which time no metastatic lesion was detected. Read More